Merck will now make JnJ vax! Less than a month after their CEO
was forced to resign because he was publicly worried about the "vaccines" and
chose to focus on treatments instead.
ex-CEO Kenneth Frazier:
“What worries me the most is that the public is so hungry, is so desperate to go back to normalcy, that they are pushing us to move things faster and faster,” Frazier said. “Ultimately, if you are going to use a vaccine in billions of people, you’d better know what that vaccine does.”
Update: Today
Merck Reportedly Set to Help Produce Johnson & Johnson Vaccine
Feb 4, 2021:
Kenneth Frazier, one of only a handful of black executives leading major US companies, will step down as chief executive officer at the end of June and be replaced by Chief Financial Officer Robert Davis
Merck ends Covid vaccine program, citing inferior immune responses
Jan 25, 2021 Drugmaker Merck on Monday said it will end development of its two Covid-19 vaccines, and will focus pandemic research on treatments
was forced to resign because he was publicly worried about the "vaccines" and
chose to focus on treatments instead.
ex-CEO Kenneth Frazier:
“What worries me the most is that the public is so hungry, is so desperate to go back to normalcy, that they are pushing us to move things faster and faster,” Frazier said. “Ultimately, if you are going to use a vaccine in billions of people, you’d better know what that vaccine does.”
Update: Today
Merck Reportedly Set to Help Produce Johnson & Johnson Vaccine
Feb 4, 2021:
Kenneth Frazier, one of only a handful of black executives leading major US companies, will step down as chief executive officer at the end of June and be replaced by Chief Financial Officer Robert Davis
Merck ends Covid vaccine program, citing inferior immune responses
Jan 25, 2021 Drugmaker Merck on Monday said it will end development of its two Covid-19 vaccines, and will focus pandemic research on treatments
